1985-48-4Relevant articles and documents
A Fit-for-Purpose Synthesis of (R)-2-Methylazepane
Guizzetti, Sylvain,Michaut, Antoine,Federspiel, Guillaume,Eymard, Julien,Caron, Isabelle,Quatrevaux, Sabrina,Daras, Etienne,Jolly, Sandrine,Guillemont, Jér?me,Lan?ois, David
supporting information, p. 729 - 733 (2020/01/31)
The preparation of new RSV inhibitors required an efficient synthesis of (R)-2-methylazepane ((R)-1) amenable to large-scale production to support preclinical studies. After consideration of different options, an efficient five-step synthesis relying on t
A Facile Direct Route to N-(Un)substituted Lactams by Cycloamination of Oxocarboxylic Acids without External Hydrogen
Li, Hu,Wu, Hongguo,Zhang, Heng,Su, Yaqiong,Yang, Song,Hensen, Emiel J. M.
, p. 3778 - 3784 (2019/08/07)
Lactams are privileged in bioactive natural products and pharmaceutical agents and widely featured in functional materials. This study presents a novel versatile approach to the direct synthesis of lactams from oxocarboxylic acids without catalyst or external hydrogen. The method involves the in situ release of formic acid from formamides induced by water to facilitate efficient cycloamination. Water also suppresses the formation of byproducts. This unconventional pathway is elucidated by a combination of model experiments and density functional theory calculations, whereby cyclic imines (5-methyl-3,4-dihydro-2-pyrrolone and its tautomeric structures) are found to be favorable intermediates toward lactam formation, in contrast to the conventional approach encompassing cascade reductive amination and cyclization. This sustainable and simple protocol is broadly applicable for the efficient production of various N-unsubstituted and N-substituted lactams.
DISUBSTITUTED AZEPAN OREXIN RECEPTOR ANTAGONISTS
-
Page/Page column 39, (2010/05/13)
The present invention is directed to disubstituted azepan and oxazepan amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin re